8-KAccepted Oct 6, 8:08 AM ET
Stryker Corp: Kevin Lobo to become executive chair; Spencer Stiles named CEO
Accepted (ET)
8:08 AM
Oct 6, 2026
Filed
Oct 6, 2026
Documents
24
Size
1.1 MB
Summary
Stryker Corp: Kevin Lobo to become executive chair; Spencer Stiles named CEO
What happened
- The filing states that on Oct 6, 2026 the company announced Kevin A. Lobo will resign as chief executive officer and transition to the role of executive chair of the board, effective Jan 1, 2027. Mr. Lobo will continue to serve as CEO through Dec 31, 2026.
- The filing states that Spencer S. Stiles, currently president and chief operating officer, has been appointed CEO, effective Jan 1, 2027. The board was increased from 10 to 11 members and Mr. Stiles was appointed to the board effective Jan 1, 2027; he has not been appointed to any board committee at this time.
Key details
- Transition agreement: the company and Mr. Lobo entered into a Transition Agreement dated Oct 5, 2026. Mr. Lobo’s annual base salary, annual bonus target and employee benefit plan eligibility will remain unchanged after the CEO transition, but he will not be eligible to receive any new stock awards while serving as executive chair.
- Letter agreement for new CEO: the company and Mr. Stiles entered into a letter agreement dated Oct 5, 2026 effective Jan 1, 2027. Mr. Stiles’s annual base salary will increase to $1,320,000 and his annual bonus target will increase to 150% of his annual base salary.
- Long-term incentive recommendation: a recommendation will be made to grant Mr. Stiles stock options and performance stock units under the company’s Long-Term Incentive Plan in Feb 2027 with an aggregate target grant date fair value equal to $14,200,000, comprising 40% stock options (vesting in equal annual installments on each of the first five anniversaries of the grant date) and 60% PSUs (vesting on Mar 21 of the year following the applicable three-year performance cycle, subject to pre-established performance goals).
- Biographical: Mr. Stiles, age 50, has served as president and chief operating officer since Jan 2026 and previously was group president, Orthopaedics, from 2019; he has 27 years of service at the company and holds a bachelor’s degree from Miami University and an MBA from the University of Nebraska.
Why it may matter
- The filing reports Item 5.02 (departure of directors or certain officers; election of directors), covering the resignation of the CEO role by Kevin A. Lobo effective Dec 31, 2026, his transition to executive chair on Jan 1, 2027, and the appointment of Spencer S. Stiles as CEO and as a director effective Jan 1, 2027. The filing also includes Regulation FD disclosure via a press release dated Oct 6, 2026.
- The filing does not show why the insider traded or why the company acted.